Meeting report: risk assessment of tamiflu use under pandemic conditions.

Singer, A; Howard, B; Johnson, A; Knowles, C; Jackman, S; Accinelli, C; Caracciolo, AB; Bernard, I; Bird, S; Boucard, T; Boxall, A; Brian, J; Cartmell, E; Chubb, C; Churchley, J; Costigan, S; Crane, M; Dempsey, M; Dorrington, B; Ellor, B; Fick, J; Holmes, J; Hutchinson, T; Karcher, F; Kelleher, S

Journal article

Meeting report: risk assessment of tamiflu use under pandemic conditions.

Abstract:: On 3 October 2007, 40 participants with diverse expertise attended the workshop Tamiflu and the Environment: Implications of Use under Pandemic Conditions to assess the potential human health impact and environmental hazards associated with use of Tamiflu during an influenza pandemic. Based on the identification and risk-ranking of knowledge gaps, the consensus was that oseltamivir ethylester-phosphate (OE-P) and oseltamivir carboxylate (OC) were unlikely to pose an ecotoxicologic hazard to freshwater organisms. OC in river water might hasten the generation of OC-resistance in wildfowl, but this possibility seems less likely than the potential disruption that could be posed by OC and other pharmaceuticals to the operation of sewage treatment plants. The work-group members agreed on the following research priorities: a) available data on the ecotoxicology of OE-P and OC should be published; b) risk should be assessed for OC-contaminated river water generating OC-resistant viruses in wildfowl; c) sewage treatment plant functioning due to microbial inhibition by neuraminidase inhibitors and other antimicrobials used during a pandemic should be investigated; and d) realistic worst-case exposure scenarios should be developed. Additional modeling would be useful to identify localized areas within river catchments that might be prone to high pharmaceutical concentrations in sewage treatment plant effluent. Ongoing seasonal use of Tamiflu in Japan offers opportunities for researchers to assess how much OC enters and persists in the aquatic environment.

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Singer, A., Howard, B., Johnson, A., Knowles, C., Jackman, S., Accinelli, C., Caracciolo, A. B., Bernard, I., Bird, S., Boucard, T., Boxall, A., Brian, J., Cartmell, E., Chubb, C., Churchley, J., Costigan, S., Crane, M., Dempsey, M., Dorrington, B., … Kelleher, S. (2008). Meeting report: risk assessment of tamiflu use under pandemic conditions. Environmental Health Perspectives, 116(11), 1563–1567.

MLA Style

Singer, A, et al. “Meeting Report: Risk Assessment of Tamiflu Use under Pandemic Conditions.” Environmental Health Perspectives, vol. 116, no. 11, 2008, pp. 1563–67.

Chicago Style

Singer, A, B Howard, A Johnson, et al. 2008. “Meeting Report: Risk Assessment of Tamiflu Use under Pandemic Conditions.” Environmental Health Perspectives 116 (11): 1563–67.
Print